Take your projections of sicko and stick 'em where you pull

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks Steel Reserve #118173
373
Take your projections of sicko and stick 'em where you pull most of your posts from, you moral imbecile.

All Signs Point to a Trump Debate Meltdown

THE END OF TEFLON DON?

Biden is eager for the chance to stand toe-to-toe with his predecessor because it will be incredibly hard to look worse in comparison.


David Rothkopf Updated May 16, 2024 9:11AM EDT Published May 15, 2024 10:20PM EDT


Photo Illustration by Thomas Levinson/The Daily Beast/Getty

https://www.thedailybeast.com/all-signs-point...e?ref=home

The news that President Joe Biden and Donald Trump have agreed to two debates—one in just a few weeks’ time, in late June, and another in September—has naturally got the punditverse buzzing.

Some commentators have focused on Biden’s sharp early morning announcement that he would welcome a debate with Trump. It was just the Egg McBiden the president’s fans—like the folks on Morning Joe—needed to start their day, served as it was with a side order of feistiness. Between the “Make my day, pal” opening and the “Let’s pick a date, Donald, I hear you’re free on Wednesdays” (a reference to his current court schedule) it got sharply to the point, did so with a humorous edge, and obligated Trump to respond.

Trump replied in character with his own statement, using his day off from his criminal election interference trial to offer an irony-deaf reference to Biden being “crooked” and to criticize the president’s debating skills. And of course there were some strangely capitalized words for emphasis.

There were, of course, commentators who offered instant speculation about Biden’s motives—like Chris Cillizza, who concluded Biden was doing this because “he knows he’s behind” and because “he knows age/competence issues aren’t going away.”

Of course, Biden actually isn’t behind Trump in the polls, with most showing the race essentially tied—and several including the most recent NYT Ipsos poll showing Biden up by 3. Further, the idea that “age” is an issue for two guys who are essentially the same age, is one that does not stand up to the slightest scrutiny. But never mind all that.

No, after talking to a number of Biden administration officials, it is clear that the primary reason Joe Biden chose to debate Donald Trump is… because he can win.

The contest is so lopsided that even Trump’s pals at the WWE could not sell a ticket to it. (I know, I know. We’ve got to manage expectations. But, do we? Really? Each time Trump debated Biden in 2020 he lost.) And ever since then, as Biden pointed out in his debate announcement, Trump has avoided debating opponents.

So, he’s bad at it and out of practice. Not a good combination.


The Biden team calculus has to be based in part on the fact that it’s Trump who is actually losing his marbles. How else do you explain his recent praise for Hannibal Lecter and his noticeably slurred words during speeches?

Furthermore, in the view of those close to Biden, Trump’s got a serious problem on the issues. He’s on the wrong side of the American public on many of the policy questions most important to them. For example, Trump keeps proclaiming he is the one responsible for the repeal of Roe v. Wade. Almost two-thirds of all women and over six out of ten men support legal abortion according to a recent Pew report. That translates into 63 percent of all Americans. That’s not a winning issue for Trump and the GOP, and recent special election results even in red states like Kansas and Ohio have shown that.

Trump does badly on other signature issues. He loves Vladimir Putin, for example. In a Pew poll last year 91 percent of Americans indicated they have an unfavorable view of Russia, with 62 percent having views that are very unfavorable. Trump’s one big legislative accomplishment was a tax cut that helped balloon the federal deficit and that tax cuts for those in the top 5 percent of earners were triple those received by the bottom 60 percent of us. Extending the cuts, as Trump has promised he would do, would add, according to the non-partisan Congressional Budget Office, almost $5 trillion to the deficit over the next 10 years.

Take Trump’s stance on another signature issue, immigration. Even though many Americans say they share his views, the reality is that when polled on his specific policies, according to a recent Washington Post study, they actually oppose them.

But set aside for a moment the fact that Trump is a lousy debater who is clearly addled and losing his ability to speak in public. And the fact that his policy positions are broadly unpopular.

And that historians consider him the worst president ever. And that Biden has a great record and has a demonstrated mastery over its details. There are other compelling issues for Biden’s team to be enthusiastic about the prospect of debating Trump.

In all likelihood, the first debate will follow by just a few weeks the conclusion of Trump’s New York election interference trial. There’s a pretty good chance Trump could emerge from the trial a convicted felon. That’s probably not a debate plus.

Even if Trump escapes a conviction, the trial has shown him in a very unflattering light and reminded the world of the sleaziest aspects of his past.

What’s more, by the time the debate takes place it is very likely the Supreme Court will have offered what will be a net unfavorable ruling on Trump’s immunity claims, thus teeing up his next dates before the bar—in Washington, D.C., Florida and Georgia. And if the court rules on Trump’s behalf—against all precedent and the very spirit on which the country was founded—it will produce an outcry about corruption on the Supreme Court that will not redound in Trump’s favor.

Further, reflecting on the New York Trial in its aftermath can’t help Trump—from its icktastic revelations about his attempts to seduce a porn star by comparing her to his daughter, to his daily sideshow at the courthouse, complete with a sycophantic chorus of back-up singers dressed exactly like him.

Indeed, the New York trial has been a revealing episode that could not be a worse prelude for a debate. It has shown once again that although Trump has virtually no deeply held political beliefs, the core of his philosophy of life is that everything is corrupt—and that money and lies are what make the world go around.

This, in turn, reveals him to be a kind of reverse neutron bomb: designed to destroy our institutions while leaving those people within it who are loyal to him still standing, or kneeling before him.

It is that Trump the world has seen in the New York trial. It is that Trump that they saw on Jan. 6. It is that Trump revealed in each of the 91 indictments against him. It is that Trump that is the clear and present danger America faces.

Biden is eager for the chance to stand toe-to-toe with his predecessor for these exact reasons. Trump’s defective character is so clear, and the danger he presents is so great, that the current president will have a hard time looking worse in comparison.

The contrasts between the two men and their beliefs could not be starker.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 97

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 82

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
AI Tool Identifies PTSD in ER: Game-changer?

Updated Category News Views 65

Pushing Boundaries: AI and Emergency Room Narratives When you think about the chaos of an emergency room, PTSD might not be the first thing that comes to mind. But for the folks developing cutting-edge AI at NYU Langone Health, it's a crucial window of opportunity. Enter PREVIA, an AI tool that’s been tapping into patients’ narratives to pinpoint PTSD risks with...

Continue Reading
TalentNeuron and CodeSignal Team Up: Impact on Workforce

Updated Category News Views 55

Skills Intelligence Takes Center Stage There's a fresh breeze blowing through the workforce planning domain, thanks to the newly expanded partnership between TalentNeuron and CodeSignal. They've strapped together their expertise to craft what's now touted as the most comprehensive skills intelligence available to organizations. A claim big enough to make us stop,...

Continue Reading
Hyperscale Data Plans Major Stock Exchange Deal

Updated Category News Views 46

Hyperscale's Bold Move: Exchange Offer Hits the Market Man, when a company believes its market value is out of whack, you get moves like this. Hyperscale Data, strutting under ticker symbol NYSE:GPUS, is swinging for the fences with an exchange offer, aiming to mop up $50 million worth of its common stock with a sweet deal that’s sure to grab any investor's attention....

Continue Reading
Terminales Portuarios Euroandinos Paita Seeks Consent to Amend Notes

Updated Category News Views 0

Initiating Amendments for Flexibility Terminales Portuarios Euroandinos Paita S.A., based over in Piura, Peru, has started the process of soliciting consents from holders of its 8.125% Series 2012-1 Senior TPE Secured Notes due 2037. These folks are looking to tweak the indenture tied up with Citibank N.A., trying to get some extra wiggle room in their operations. We’re...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 83

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 191

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Expedera Teams Up with Cadence for Edge AI Supercharge

Updated Category News Views 36

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...

Continue Reading

Top 5 Most Recently Viewed Articles

Elutia Marks Milestone with First Patient Implant of EluPro

Updated Category News Views 190

Significant Advancements in Cardiac Technology Elutia Inc. (NASDAQ: ELUT) has made a remarkable impact in the medical technology sector with the successful first patient implant of EluPro, a groundbreaking antibiotic-eluting biologic envelope tailored for cardiac pacemakers and neurostimulators. This achievement marks a pivotal moment for Elutia, a frontrunner in creating...

Continue Reading
Cook Smarts Revolutionizes Meal Planning with New App Release

Updated Category News Views 207

Cook Smarts Unveils Innovative Meal Planning App In a world where managing daily meals can be daunting, Cook Smarts LLC has launched a groundbreaking iOS mobile app designed to transform the meal planning experience. This convenient application aims to cut down on food waste and alleviate the stress connected to daily meal preparations, catering to home cooks seeking an...

Continue Reading
Lottery.com Inc. Takes Steps Towards Compliance with NASDAQ

Updated Category News Views 129

Lottery.com Inc. Faces Compliance Notification from NASDAQ Lottery.com Inc. received an important notification from NASDAQ regarding its financial reporting. This occurrence highlights significant compliance issues faced by many publicly listed companies in today's competitive market. On November 20, the company was informed about a delay in filing the Form 10-Q for the...

Continue Reading
Norris McLaughlin Expands Expertise with New Hires

Updated Category News Views 15

Norris McLaughlin Grows Its Utility Practice In a move that's cooking up interest, Norris McLaughlin, P.A. has decided to beef up its Public Utilities, Telecommunications, and Energy practice. By bringing Martin C. Rothfelder and Bradford M. Stern into the fold, they're not just adding any courtroom rookies. These are seasoned pros whose resumes read like a who's who of...

Continue Reading
Revolutionary Cancer Study by Etcembly and Surrey Researchers

Updated Category News Views 71

Revolutionary Approach to Cancer Treatment Development In an exciting collaboration, British techbio innovator Etcembly is partnering with esteemed researchers and clinicians from the University of Surrey to unveil a pioneering study that holds the potential to redefine the landscape of cancer treatment. This innovative research focuses on analyzing immune cells derived...

Continue Reading